Pioglitazone attenuates progression of aortic valve calcification via down-regulating receptor for advanced glycation end products
The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Receptor for advanced glycation end products (RAGE) is associated with inflammation and the progression of cardiovascular diseases. The current study tested the hypothesis that RAGE is involved in the pathogenesis of aortic valve (AV) calcification. Pioglitazone attenuated AV calcification in experimental hypercholesterolemic rabbits via down-regulation of RAGE. Male New Zealand rabbits weighing 2.5-3.0 kg were randomly divided into three groups: control group, high cholesterol + vitamin D(2) (HC + vitD(2)) group and HC + vitD(2) supplemented with pioglitazone group. Compared with HC + vitD(2) group, pioglitazone significantly inhibited the progression of AV calcification assessed by echocardiography. HC + vitD(2) diet markedly increased RAGE expression, oxidative stress, inflammatory cells infiltration and osteopontin expression. These changes were also significantly attenuated by administration of pioglitazone. Cultured porcine aortic valve interstitial cells (VICs) were used as in vitro model. We found that advanced glycation end products of bovine serum albumin markedly increased the expression of RAGE, induced high levels of production of pro-inflammatory cytokines and promoted osteoblastic differentiation of VICs. However, these effects were found to be remarkably suppressed by siRNA silencing of RAGE and pioglitazone as well. Our data provide evidence that RAGE activation-induced inflammation promotes AV calcification in hypercholesterolemic rabbits, which can be attenuated by pioglitazone treatment. This beneficial effect is associated with remarkable down-regulation of RAGE expression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, pioglitazone, a PPARγ agonist, has been shown to reduce aortic valve calcification in mice, rabbit and swine models.43,45,46”
From Transcriptomic signatures of calcific aortic valve stenosis severity in human tricuspid and bicuspid aortic valves (2025) · cites this paper as [45]
Citations
Cites
Burden of valvular heart diseases: a population-based study
Nkomo, V. T., Gardin, J. M., Skelton, T. N., Gottdiener, J. S., Scott, C. G., & Enriquez-Sarano, M. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69208-8 · Cited by 4,881 · cited 1×
“8 % of adults over 75 years old have some degree of AV calcification [5, 34], and up to 25 % of adults over 65 have valvular sclerosis [3].”
BackgroundThe peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J., & Glass, C. K. (1998) · Nature · doi:10.1038/34178 · Cited by 3,525 · cited 1×
“PPARc agonists possess anti-inflammatory and anti-oxidant properties [40].”
BackgroundBonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C., Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., O'Gara, P. T., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.05.007 · Cited by 2,257
Neeper, M., Schmidt, A. M., Brett, J., Yan, S. D., Wang, F., Pan, Y. C., Elliston, K., Stern, D., & Shaw, A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42138-2 · Cited by 1,541 · cited 1×
“Receptor for advanced glycation end products (RAGE) is a multi-ligand receptor expressed in a range of cell types, including endothelial, smooth muscle, mesangial and mononuclear cells [6, 33].”
BackgroundOtto, C. M., Kuusisto, J., Reichenbach, D. D., Gown, A. M., & O'Brien, K. D. (1994) · Circulation · doi:10.1161/01.cir.90.2.844 · Cited by 1,315 · cited 2×
“that AV calcification has many features characteristic of an active pathobiological process akin to atherosclerosis, including chronic inflammation, endothelial dysfunction, lipoprotein deposition and extracellular matrix remodeling [36, 37].”
Background2006 WRITING COMMITTEE MEMBERS, Bonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C., Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., et al. (2008) · Circulation · doi:10.1161/circulationaha.108.190748 · Cited by 1,114
Rajamannan, N. M., Evans, F. J., Aikawa, E., Grande-Allen, K. J., Demer, L. L., Heistad, D. D., Simmons, C. A., Masters, K. S., Mathieu, P., O'Brien, K. D., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.006767 · Cited by 842 · cited 1×
“Transition from VICs to myofibroblasts is a critical step in valvular pathology [39].”
BackgroundBrett, J., Schmidt, A. M., Yan, S. D., Zou, Y. S., Weidman, E., Pinsky, D. J., Nowygrod, R., Neeper, M. P., Przysiecki, C. T., & SHAW, A. R. (1993) · PubMed · Cited by 780
Soro-Paavonen, A., Watson, A. M. D., Li, J., Paavonen, K., Koitka, A., Calkin, A. C., Barit, D., Coughlan, M. T., Drew, B. G., Lancaster, G. I., et al. (2008) · Diabetes · doi:10.2337/db07-1808 · Cited by 407 · cited 1×
“Strategies targeting to inactivate RAGE promote plaque stabilization and inhibit the progression of atherosclerotic changes [29, 41, 44].”
BackgroundVascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE–/– mice
Harja, E., Bu, D.-X., Hudson, B. I., Chang, J. S., Shen, X., Hallam, K., Kalea, A. Z., Lu, Y., Rosario, R. H., Oruganti, S., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32703 · Cited by 364 · cited 1×
“Previous studies have indicated that the vascular and inflammatory stresses mediated by interaction between RAGE and its ligands, such as AGEs, play a central role in the development of accelerated atherosclerosis [13].”
Background
Cited by
Aldini, G., Vistoli, G., Stefek, M., Chondrogianni, N., Grune, T., Sereikaite, J., Sadowska-Bartosz, I., & Bartosz, G. (2013) · Free Radical Research · doi:10.3109/10715762.2013.792926 · Cited by 150
“RAGE activation-induced inflammation promotes aortic valve calcification in hypercholesterolemic rabbits, which can be attenuated by pioglitazone treatment [508].”
BackgroundInfluentialRethinking pioglitazone as a cardioprotective agent: a new perspective on an overlooked drug
Nesti, L., Tricò, D., Mengozzi, A., & Natali, A. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01294-7 · Cited by 124
“It also reduced aortic valve calcification in non-diabetic, hypercholesterolemic rats [47].”
BackgroundEvaluating Medical Therapy for Calcific Aortic Stenosis
Lindman, B. R., Sukul, D., Dweck, M. R., Madhavan, M. V., Arsenault, B. J., Coylewright, M., Merryman, W. D., Newby, D. E., Lewis, J., Harrell, F. E., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.09.1367 · Cited by 111
Fibrocalcific Aortic Valve Disease: Opportunity to Understand Disease Mechanisms Using Mouse Models
Weiss, R. M., Miller, J. D., & Heistad, D. D. (2013) · Circulation Research · doi:10.1161/circresaha.113.300153 · Cited by 102
Kopytek, M., Ząbczyk, M., Mazur, P. K., Undas, A., & Natorska, J. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01068-7 · Cited by 97
Metadata
- Authors
- Li, F., Cai, Z., Chen, F., Shi, X., Zhang, Q., Chen, S., Shi, J., Wang, D. W., & Dong, N.
- Affiliations
- Wuhan Union Hospital (CN)
- Second Affiliated Hospital of Zhejiang University (CN)
- Henan Provincial People's Hospital (CN)
- Huazhong University of Science and Technology (CN)
- Tongji Hospital (CN)
- Corresponding author
- Wang, Dao Wen
- Dong, Nianguo
- Venue
- Basic Research in Cardiology
- Published
- 2012-10-16
- Volume
- 107
- Issue
- 6
- Pages
- 306-306
- ISSN
- 0003-9217 (ISSN-L)
- 0300-8428
- 1435-1803
- OpenAlex
- W2043671515
- Cited by
- 67
- References
- 53
- Citations by year
- 2026: 1 · 2025: 9 · 2024: 4 · 2023: 4 · 2022: 2 · 2021: 8 · 2020: 6 · 2018: 4 · 2017: 3 · 2016: 6 · 2015: 5 · 2014: 10 · 2013: 5
- FWCI
- 4.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Basic Research in Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Valve Diseases and Treatments
- Health Sciences › Medicine › Nephrology › Parathyroid Disorders and Treatments
- Keywords
- pioglitazone, aortic valve calcification, receptor for advanced glycation end products, advanced glycation end products, hypercholesterolemia, vitamin D2, oxidative stress, inflammation, osteopontin, aortic valve interstitial cells, osteogenic differentiation, inflammatory cytokines, siRNA knockdown
- MeSH terms
- Receptor for Advanced Glycation End Products, Pioglitazone, Animals, Aortic Valve, Aortic Valve Stenosis, Calcinosis, Cell Differentiation, Drug Evaluation, Preclinical, Echocardiography, Hypoglycemic Agents, Immunohistochemistry, Male, Osteoblasts, Rabbits, Receptors, Immunologic, Down-Regulation, Thiazolidinediones, PPAR gamma
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pioglitazone attenuates progression of aortic valve calcification via down-regulating receptor for advanced glycation end products. https://app.cochat.ai/papers/10.1007/s00395-012-0306-0
- The paper
- Li, F., Cai, Z., Chen, F., Shi, X., Zhang, Q., Chen, S., Shi, J., Wang, D. W., & Dong, N. (2012). Pioglitazone attenuates progression of aortic valve calcification via down-regulating receptor for advanced glycation end products. Basic Research in Cardiology. https://doi.org/10.1007/s00395-012-0306-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.